Found: 2
Select item for more details and to access through your institution.
C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repair.
- Published in:
- Frontiers in Molecular Neuroscience, 2024, p. 1, doi. 10.3389/fnmol.2024.1411384
- By:
- Publication type:
- Article
Modeling gene-regulatory networks to describe cell fate transitions and predict master regulators.
- Published in:
- NPJ Systems Biology & Applications, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41540-018-0066-z
- By:
- Publication type:
- Article